A ground-breaking new accelerator programme is set to launch for businesses using technology to tackle the world’s most pressing healthcare challenges.
The ‘HS.’ programme will build and scale healthcare technology businesses, help larger organisations drive healthcare innovation at a corporate level and position the UK at the forefront of innovation in global healthcare.
More than $23bn has been invested in healthcare start ups globally over the past seven years. However, few accelerator programmes are in place to sustainably launch and scale these health-tech businesses - and even fewer are able to offer their members deep insights and guidance on how to successfully bring healthcare technologies to market.
HS. will therefore fill this gap, with a programme built around the needs of health-tech start ups and an unparalleled team of healthcare experts and mentors. The accelerator aims to bring the most talented individuals and most innovative companies together to work on solutions for the world’s largest healthcare problems.
Dr Alex Young, CEO and co-founder of HS. explained: “Healthcare is on the cusp of radical transformation, and for the first time we will soon begin taking charge of our own health data. The HS. programme will harness the potential that change holds and bring together brilliant minds with a singular focus: solving the world’s most pressing healthcare challenges with technology.
“Impact comes from scale, and we want to build UK health companies that scale internationally - to impact patients around the world and make the UK a hub of excellence for health-tech.”
Dr. Young is a trauma and orthopaedic surgeon by training. His latest company, Virti, is an immersive video training platform based in Silicon Valley and London. Dr. James Somauroo, his co-founder and CPO, has most recently led the Digital Health London Accelerator - a £3.4mn project in partnership with NHS organisations, healthcare charities, MedCity and the EU Regional Development Fund, providing market access to the NHS for high-potential healthcare businesses. He was also previously an Innovation Fellow for NHS England.
The HS. co-founders are joined by a seasoned group of clinical experts, startup advisors and mentors from the likes of Healthcare UK, MedCity, the BMJ, Department for International Trade, Johnson & Johnson and Philips.
For entrepreneurs and scale-ups, the HS. programme will place an emphasis on guiding and developing them as individuals and as businesses - and equip them with deep insights on how to achieve ‘product-patient fit’, matching them with clinical experts and patient groups even in their early stages.
At an event hosted by the Royal Society of Medicine in London today, HS. will also reveal its first cohort of entrepreneurs - 30 talented individuals across 13 companies, who were chosen from over 1,000 applicants after a rigorous selection process that focused on ‘talent and traction, before idea’. The first HS. cohort comprises of:
Dr. Somauroo, co-founder and CPO, adds: “The HS. founding team have broken down the traditional model of accelerator programmes, and rebuilt it specifically for building, scaling and innovating in healthcare while putting patients first. With our first cohort of businesses on board and the programme now open to corporate partners, we look forward to guiding their journey in tackling some of the world’s biggest healthcare problems with technology.”